164 related articles for article (PubMed ID: 32171575)
21. Cost-utility analysis of dengue vaccination in a country with heterogeneous risk of dengue transmission.
Orellano PW; Reynoso JI; Stahl HC; Salomon OD
Vaccine; 2016 Jan; 34(5):616-621. PubMed ID: 26724542
[TBL] [Abstract][Full Text] [Related]
22. Economic evaluation of pneumococcal conjugate vaccination in The Gambia.
Kim SY; Lee G; Goldie SJ
BMC Infect Dis; 2010 Sep; 10():260. PubMed ID: 20815900
[TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness of pneumococcal conjugate vaccination in Croatia.
Vučina VV; Filipović SK; Kožnjak N; Stamenić V; Clark AD; Mounaud B; Blau J; Hoestlandt C; Kaić B
Vaccine; 2015 May; 33 Suppl 1():A209-18. PubMed ID: 25919163
[TBL] [Abstract][Full Text] [Related]
24. Modeling the economic and epidemiologic impact of hookworm vaccine and mass drug administration (MDA) in Brazil, a high transmission setting.
Bartsch SM; Hotez PJ; Hertenstein DL; Diemert DJ; Zapf KM; Bottazzi ME; Bethony JM; Brown ST; Lee BY
Vaccine; 2016 Apr; 34(19):2197-206. PubMed ID: 27002501
[TBL] [Abstract][Full Text] [Related]
25. Modeling the economic value of a Chagas' disease therapeutic vaccine.
Lee BY; Bacon KM; Wateska AR; Bottazzi ME; Dumonteil E; Hotez PJ
Hum Vaccin Immunother; 2012 Sep; 8(9):1293-301. PubMed ID: 22894964
[TBL] [Abstract][Full Text] [Related]
26. Updated cost-effectiveness and risk-benefit analysis of two infant rotavirus vaccination strategies in a high-income, low-endemic setting.
Bruijning-Verhagen P; van Dongen JAP; Verberk JDM; Pijnacker R; van Gaalen RD; Klinkenberg D; de Melker HE; Mangen MJ
BMC Med; 2018 Sep; 16(1):168. PubMed ID: 30196794
[TBL] [Abstract][Full Text] [Related]
27. Cost-effectiveness of HPV vaccination in 195 countries: A meta-regression analysis.
Rosettie KL; Joffe JN; Sparks GW; Aravkin A; Chen S; Compton K; Ewald SB; Mathew EB; Michael D; Pedroza Velandia P; Miller-Petrie MB; Stafford L; Zheng P; Weaver MR; Murray CJL
PLoS One; 2021; 16(12):e0260808. PubMed ID: 34928971
[TBL] [Abstract][Full Text] [Related]
28. Affordability of Adult Tuberculosis Vaccination in India and China: A Dynamic Transmission Model-Based Analysis.
Weerasuriya CK; Harris RC; Quaife M; McQuaid CF; White RG; Gomez GB
Vaccines (Basel); 2021 Mar; 9(3):. PubMed ID: 33799544
[TBL] [Abstract][Full Text] [Related]
29. Economic value of dengue vaccine in Thailand.
Lee BY; Connor DL; Kitchen SB; Bacon KM; Shah M; Brown ST; Bailey RR; Laosiritaworn Y; Burke DS; Cummings DA
Am J Trop Med Hyg; 2011 May; 84(5):764-72. PubMed ID: 21540387
[TBL] [Abstract][Full Text] [Related]
30. Economic impact of a rotavirus vaccination program in Mexico.
Constenla D; Velázquez FR; Rheingans RD; Antil L; Cervantes Y
Rev Panam Salud Publica; 2009 Jun; 25(6):481-90. PubMed ID: 19695142
[TBL] [Abstract][Full Text] [Related]
31. Cost-effectiveness analysis of influenza vaccination during pregnancy in Japan.
Hoshi SL; Shono A; Seposo X; Okubo I; Kondo M
Vaccine; 2020 Oct; 38(46):7363-7371. PubMed ID: 33020012
[TBL] [Abstract][Full Text] [Related]
32. Potential cost-effectiveness of vaccination for rotavirus gastroenteritis in eight Latin American and Caribbean countries.
Rheingans RD; Constenla D; Antil L; Innis BL; Breuer T
Rev Panam Salud Publica; 2007 Apr; 21(4):205-16. PubMed ID: 17612464
[TBL] [Abstract][Full Text] [Related]
33. Breastfeeding promotion and priority setting in health.
Horton S; Sanghvi T; Phillips M; Fiedler J; Perez-Escamilla R; Lutter C; Rivera A; Segall-Correa AM
Health Policy Plan; 1996 Jun; 11(2):156-68. PubMed ID: 10158457
[TBL] [Abstract][Full Text] [Related]
34. Impact and cost-effectiveness of potential interventions against infant respiratory syncytial virus (RSV) in 131 low-income and middle-income countries using a static cohort model.
Baral R; Higgins D; Regan K; Pecenka C
BMJ Open; 2021 Apr; 11(4):e046563. PubMed ID: 33895717
[TBL] [Abstract][Full Text] [Related]
35. Economic evaluation of Chagas disease screening in Spain.
Imaz-Iglesia I; Miguel LG; Ayala-Morillas LE; García-Pérez L; González-Enríquez J; Blasco-Hernández T; Martín-Águeda MB; Sarría-Santamera A
Acta Trop; 2015 Aug; 148():77-88. PubMed ID: 25917718
[TBL] [Abstract][Full Text] [Related]
36. The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug-resistant tuberculosis in India and China.
Weerasuriya CK; Harris RC; McQuaid CF; Bozzani F; Ruan Y; Li R; Li T; Rade K; Rao R; Ginsberg AM; Gomez GB; White RG
BMC Med; 2021 Feb; 19(1):60. PubMed ID: 33632218
[TBL] [Abstract][Full Text] [Related]
37. Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa.
Kim JJ; Campos NG; O'Shea M; Diaz M; Mutyaba I
Vaccine; 2013 Dec; 31 Suppl 5():F60-72. PubMed ID: 24331749
[TBL] [Abstract][Full Text] [Related]
38. Economic evaluation of rotavirus vaccination in children of Bhutan.
Pempa ; Luz ACG; Luangasanatip N; Kingkaew P; Adhikari D; Isaranuwatchai W; Choiphel D; Pecenka C; Debellut F
Vaccine; 2020 Jul; 38(32):5049-5059. PubMed ID: 32522415
[TBL] [Abstract][Full Text] [Related]
39. Cost-effectiveness of pneumococcal conjugate vaccination in the prevention of child mortality: an international economic analysis.
Sinha A; Levine O; Knoll MD; Muhib F; Lieu TA
Lancet; 2007 Feb; 369(9559):389-96. PubMed ID: 17276779
[TBL] [Abstract][Full Text] [Related]
40. The economic value of childhood varicella vaccination in France and Germany.
Coudeville L; Brunot A; Szucs TD; Dervaux B
Value Health; 2005; 8(3):209-22. PubMed ID: 15877593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
